Literature DB >> 29133174

ABCA1 rs2230805 and rs2230806 common gene variants are associated with Alzheimer's disease.

Ágnes Fehér1, Zsófia Giricz2, Anna Juhász2, Magdolna Pákáski2, Zoltán Janka2, János Kálmán2.   

Abstract

The ATP-binding cassette, sub-family A, member 1 gene (ABCA1) is a relevant positional and functional candidate gene for Alzheimer's disease (AD). A case-control association study of genetic variations covering the ABCA1 locus was performed in relation to AD risk in a Hungarian sample. Five single nucleotide polymorphisms (rs2422493: C-477T, rs2740483: G-17C, rs2230805: G474A/L158L, rs2230806: G656A/R219K and rs2066718: G2311A/V771M) were genotyped in 431 AD patients and 302 cognitively healthy, elderly controls. In single marker analysis, significant associations were found in the case of rs2230805 and rs2230806 polymorphisms: the minor A allele containing genotypes for both polymorphisms were more frequent in the control compared to the AD group. Haplotype analysis revealed that rs2230805, rs2230806 and rs2066718 polymorphisms created a linkage disequilibrium (LD) block with a strong LD between rs2230805 and rs2230806 polymorphisms. In the haplotype risk association tests, A-A-G haplotype of the rs2230805-rs2230806-rs2066718 polymorphisms was found to be nominally significantly more frequent in the control group. After correcting p values for multiple testing, only the effects of the rs2230805 and rs2230806 polymorphisms remained significant in the recessive model suggesting a modest protective effect of their minor alleles in AD, which should be interpreted with considerable caution, until further studies elucidate their role in AD pathology.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATP-binding cassette transporter subfamily A member 1 (ABCA1); Alzheimer’s disease; Association study; Single nucleotide polymorphism (SNP)

Mesh:

Substances:

Year:  2017        PMID: 29133174     DOI: 10.1016/j.neulet.2017.11.027

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

Review 1.  Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia.

Authors:  Ramon Cacabelos
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

2.  Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and Development.

Authors:  Ramón Cacabelos; Vinogran Naidoo; Olaia Martínez-Iglesias; Lola Corzo; Natalia Cacabelos; Rocío Pego; Juan C Carril
Journal:  Methods Mol Biol       Date:  2022

Review 3.  The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans.

Authors:  Kaitlyn E Stepler; Renã A S Robinson
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

4.  Neuronal ROS-induced glial lipid droplet formation is altered by loss of Alzheimer's disease-associated genes.

Authors:  Matthew J Moulton; Scott Barish; Isha Ralhan; Jinlan Chang; Lindsey D Goodman; Jake G Harland; Paul C Marcogliese; Jan O Johansson; Maria S Ioannou; Hugo J Bellen
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-28       Impact factor: 12.779

Review 5.  The Role of the ATP-Binding Cassette A1 (ABCA1) in Human Disease.

Authors:  Leonor Jacobo-Albavera; Mayra Domínguez-Pérez; Diana Jhoseline Medina-Leyte; Antonia González-Garrido; Teresa Villarreal-Molina
Journal:  Int J Mol Sci       Date:  2021-02-05       Impact factor: 5.923

Review 6.  Protective genes and pathways in Alzheimer's disease: moving towards precision interventions.

Authors:  Mabel Seto; Rebecca L Weiner; Logan Dumitrescu; Timothy J Hohman
Journal:  Mol Neurodegener       Date:  2021-04-29       Impact factor: 14.195

Review 7.  Solving neurodegeneration: common mechanisms and strategies for new treatments.

Authors:  Lauren K Wareham; Shane A Liddelow; Sally Temple; Larry I Benowitz; Adriana Di Polo; Cheryl Wellington; Jeffrey L Goldberg; Zhigang He; Xin Duan; Guojun Bu; Albert A Davis; Karthik Shekhar; Anna La Torre; David C Chan; M Valeria Canto-Soler; John G Flanagan; Preeti Subramanian; Sharyn Rossi; Thomas Brunner; Diane E Bovenkamp; David J Calkins
Journal:  Mol Neurodegener       Date:  2022-03-21       Impact factor: 18.879

8.  Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation.

Authors:  Ethan B Russo; Chris Spooner; Len May; Ryan Leslie; Venetia L Whiteley
Journal:  Cannabis Cannabinoid Res       Date:  2021-07-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.